Potential concerns about generic substitution: bioequivalence versus therapeutic equivalence of different amlodipine salt forms

Author： Meredith Peter A.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.25, Iss.9, 2009-09, pp. : 2179-2189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Generic lamotrigine versus brand‐name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard

By  

EPILEPSIA, Vol. 56, Iss. 9, 2015-09 ,pp. : 1415-1424

John Wiley & Sons Inc

Access to resources Recommend Favorite

Concerns about raising concerns

By  

MEDICAL EDUCATION, Vol. 49, Iss. 5, 2015-05 ,pp. : 514-515

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical case reports raise doubts about the therapeutic equivalence of an iron sucrose similar preparation compared with iron sucrose originator

By Stein Jürgen   Dignass Axel   Chow Kai Uwe  

Current Medical Research and Opinion, Vol. 28, Iss. 2, 2012-02 ,pp. : 241-243

Informa Healthcare

Access to resources Recommend Favorite

Generic substitution in contravention of doctor's prescriptions

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 10, 2015-10 ,pp. : 1093-1093

John Wiley & Sons Inc

Access to resources Recommend Favorite

Concerns of ABO incompatible and crossmatch‐positive potential donors and recipients about participating in kidney exchanges

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 3, 2015-03 ,pp. : 233-241

John Wiley & Sons Inc

Access to resources Recommend Favorite